Claims

What Nerve Recovery Max is sold as, and what the sources publish

Nerve Recovery Max is sold as nerve-comfort support, which is a category rather than an outcome, and the Supplement Facts panel carries no benefit line at all. A phrase of that kind is a permitted form of words about a normal structure or function of the body rather than a finding, and no requirement that the finished product was tested comes with it. Six of the ten declared things have a published federal sentence. Two are findings that the evidence is not there, one is a conclusion hedged in its own words, one reports a range the printed amount sits inside, one belongs to a different condition and one describes a deficiency. Six of the ten declared things are addressed by no federal source this desk opened in connection with nerve pain. That is the state of what could be read rather than a verdict on any of them.

By the Mynerverecoverymax Editorial Desk · Last updated October 12, 2026

Written by the Nerve Recovery Max editorial teamLast updated October 12, 2026Medically reviewed by Dr. Edgar Martorell, MD, Physician

Role Medical reviewerReview date October 12, 2026

Not yet reviewed by a clinician. This page is written and checked by the editorial desk against the label and the sources it cites. When a named clinician reviews it, their name and the date go in the slot above.

Check 01

What the product is sold as, and what the label prints

On most products the advert, the bottle and the sources say roughly the same thing in three registers. Here they do not meet, and keeping them apart is most of the work of this page.

Nerve Recovery Max is sold as nerve-comfort support. A category is not an outcome: it says where a product sits on a shelf rather than what it will do to anybody. The panel carries no benefit line of any kind, no asterisked support claim and no sentence that would need a source behind it. That is the second credit this label earns; the first is that it prints every amount.

The category, as the product is sold. Nerve-comfort support. No outcome and no timeline is attached to it in any supplied material.
The label’s own words. A panel, an Other Ingredients line and a distributor block. Ten amounts and no promise.
What is explicitly not claimed. Not a drug, not a neuropathy medicine and not a treatment for nerve damage.
The finished formula. No published trial on this formula was supplied, and none appears in any source this desk opened.

One sentence from the agency that owns this condition governs the page, and it is not one a claims page usually carries: “Diabetes experts have not made special recommendations about supplements for people with diabetes.” ^NIDDK

10 amounts, printed, with no proprietary blend. A serving is 2 capsules and the bottle holds 30 of them.

10 amounts printed, none in a blend
2 capsules a serving, 30 servings a bottle
Price and terms shown at checkout, before you pay

See the price

Check 02

What a structure and function claim is, and is not

The phrase this product is sold under belongs to a category of wording with rules of its own, and the rules are narrower than most readers assume.

A structure and function claim is a permitted form of words about a normal structure or function of the body. Saying a product supports nerve comfort is such a claim. Saying it treats, reverses, cures or manages neuropathy is not, and none of those words appears in the supplied material.

What a claim of that kind does not carry is any requirement that the finished product was tested. It is a category of wording rather than a category of evidence, and the statement that must accompany one says exactly that: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

So the useful question is never whether the wording is permitted. It is what is published behind it.

Supplied, not verified

The seller's own benefits panel, as supplied

The seller's benefits panel, a stacked list of claimed supports beside the Nerve Recovery Max bottle — The panel on the bottle carries no benefit line at all.

Reproduced from the stock pack supplied with this product; not verified here.

Check 03

Every published federal sentence that touches this label

Six of the ten declared things have a sentence in a federal source this desk opened. Here are all six, with the printed amount beside each.

Every declared ingredient with a published federal sentence.
Ingredient	On this panel	What the source says	Dose published	Source
Alpha Lipoic Acid	400 mg	alpha-lipoic acid might be helpful for reducing pain associated with diabetic neuropathy	600 mg a day	^{NCCIH · NIH ODS}
Benfotiamine	150 mg	Three studies found that, compared to placebo, 120–900 mg/day benfotiamine with or without other B-vitamins decreased the severity of neuropathy symptoms	120 to 900 mg a day	^{NIH ODS}
Acetyl L-Carnitine	50 mg	The effects of acetyl-L-carnitine supplements in Alzheimer’s disease and other forms of dementia remain unclear	1 to 3 grams a day	^{NIH ODS}
Ashwagandha Powder (Root)	25 mg	There isn’t enough evidence to determine if ashwagandha is helpful for any other health conditions	Not published	^NCCIH
Turmeric Powder (Root)	25 mg	We don’t know enough to definitively conclude if turmeric or curcumin is beneficial for any health purposes.	Not published	^NCCIH
Vitamin B12 (as Methylcobalamin)	2 mcg	Neurological changes, such as numbness and tingling in the hands and feet, can also occur	Not published	^{NIH ODS}

Read the shape of that column rather than the rows. Two of the six sentences are findings that the evidence is not there: “There isn’t enough evidence to determine if ashwagandha is helpful for any other health conditions” ^NCCIH on ashwagandha, and “We don’t know enough to definitively conclude if turmeric or curcumin is beneficial for any health purposes.” ^NCCIH on turmeric. A claims page leaving those out would be dishonest by omission.

One is a conclusion with a hedge built into it, on the heaviest ingredient here, and how it is said to work works it through. One reports what three studies found at a range the printed amount sits inside, which is the strongest row and is stated as plainly as the weak ones. One is about a different condition. And the B12 row is the easiest to misread: numbness and tingling appear there as a deficiency symptom rather than as something a supplement relieves.

Six of the ten declared things are addressed by no federal source this desk opened in connection with nerve pain. That is the state of what could be read rather than a verdict on any of them. Where an agency has published nothing, a claim cannot be contradicted at all, and neither can it be supported.

Check 04

Two kinds of silence, and the credit the label has earned

This page has found two silences and they are not the same thing. One belongs to the sources. The other belongs to the label, and it is to the label’s credit.

The sources are silent on most of this formula

Six of the ten declared things have no federal statement connecting them to nerve pain, and one has no federal fact sheet of any kind. The ingredients page prints the reason for each.

The label is silent about benefits, which is different

No benefit line, no outcome, no timeline and no asterisked support claim appears on the panel. A manufacturer is permitted to make such claims, and this one makes none.

What the label is not silent about

The amounts. All ten, with no proprietary blend, the form named for each nutrient and the plant part for each botanical.

What that combination means here

Very little to argue with and very little to rely on. The strongest thing publishable is that one printed amount sits inside one published range, with the agency’s own request for better studies attached.

This site never cites PubMed or PMC as a federal finding: the National Library of Medicine runs that index, and an entry in it is not an agency position.

Check 05

What this page will not say, and why

Four sentences a page like this usually carries. None appears anywhere on this site, and each is left out for a reason a reader can check.

It will not say the product works. No published trial on this formula was supplied, and none appears in any source this desk opened. Every source cited here describes one named ingredient or a labelling regulation, not a result measured on this capsule.
It will not say the product does not work. The same absence cuts both ways.
It will not compare this product with another, because a reader here cannot see any other product and the comparison could not be checked.
It will not give a timeline. The timeline page sets out why.

In one paragraph

Nerve Recovery Max is sold as nerve-comfort support, a category rather than a promise, and the panel claims nothing. Six of the ten declared things have a published federal sentence: two are findings that the evidence is not there, one is a hedged conclusion, one reports a range the printed amount sits inside, one belongs to a different condition and one describes a deficiency rather than a treatment. Six of the ten declared things are addressed by no federal source this desk opened in connection with nerve pain. That is the state of what could be read rather than a verdict on any of them. What this label does better than the sources manage is the amounts: all ten printed, nothing pooled. NIDDK owns this condition and publishes the sentence these pages treat as the most important on them: “For safety reasons, talk with your doctor before using supplements or any complementary or alternative medicines.” ^NIDDK Peripheral neuropathy has causes that need diagnosing, and some are treatable.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Questions

Nerve Recovery Max: common questions

What does Nerve Recovery Max claim to do?

It is sold as nerve-comfort support, a category rather than an outcome, and the Supplement Facts panel carries no benefit line at all. A phrase of that kind is a permitted form of words about a normal structure or function of the body rather than a finding. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Is Nerve Recovery Max good for neuropathy?

Nothing supplied with this stock supports an answer and no federal source this desk opened gives one for this formula. No published trial on this formula was supplied, and none appears in any source this desk opened. The agency that owns the condition publishes “Diabetes experts have not made special recommendations about supplements for people with diabetes.”

What evidence is there behind the Nerve Recovery Max ingredients?

One federal page states a neuropathy conclusion and hedges it: NCCIH on alpha lipoic acid, “alpha-lipoic acid might be helpful for reducing pain associated with diabetic neuropathy”. One reports a range in which three studies found an effect, for benfotiamine. On ashwagandha, NCCIH: “There isn’t enough evidence to determine if ashwagandha is helpful for any other health conditions”. On turmeric: “We don’t know enough to definitively conclude if turmeric or curcumin is beneficial for any health purposes.”

Does the vitamin B12 in Nerve Recovery Max help nerve pain?

The NIH ODS vitamin B12 page never uses the words neuropathy or nerve damage. Numbness and tingling appear there as symptoms of a deficiency: “Neurological changes, such as numbness and tingling in the hands and feet, can also occur”. That is a different claim from a finding that more of it relieves nerve pain.

Does Nerve Recovery Max have a benefit printed on the label?

No. The panel carries no benefit line, no asterisked support claim and no outcome. That is worth crediting: a label promising less than its advert has promised less.

References

National Center for Complementary and Integrative Health. Diabetes and Dietary Supplements. https://www.nccih.nih.gov/health/diabetes-and-dietary-supplements
NIH Office of Dietary Supplements. Primary Mitochondrial Disorders: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/PrimaryMitochondrialDisorders-HealthProfessional/
NIH Office of Dietary Supplements. Thiamin: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Thiamin-HealthProfessional/
NIH Office of Dietary Supplements. Carnitine: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Carnitine-HealthProfessional/
NIH Office of Dietary Supplements. Vitamin B12: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/
National Center for Complementary and Integrative Health. Ashwagandha. https://www.nccih.nih.gov/health/ashwagandha
National Center for Complementary and Integrative Health. Turmeric. https://www.nccih.nih.gov/health/turmeric
National Institute of Diabetes and Digestive and Kidney Diseases. Peripheral Neuropathy. https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/nerve-damage-diabetic-neuropathies/peripheral-neuropathy

Every source above was opened and read on October 12, 2026. None of them tested Nerve Recovery Max itself. They describe single ingredients and the categories they sit in, which is a different thing from testing this finished formula.

Keep reading